HR 3546

Official Title: To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.

Introduced: 2025-05-21

Passed House:

Passed Senate:

To President:

Became Law:

Categories: Health/Group House Introduced
A summary is in progress.

Action(s)

  • 05/21/2025 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 05/21/2025 - Introduced in House

Bill Details

  • Prescription Drug Price Relief Act of 2025

    Short Title

  • House

    Type

  • 119

    Congress Number

  • HR3546-119

    Full Number

View on Congress.gov

Sponsor

Rep. Khanna, Ro [D-CA-17]

Rep.